Endocrinology · 2003 · 56 citations · 42 references
Life SciencesCell BiologyPharmacologyApoptosisCellular PharmacologyMitochondrial BiologyApoptosis ModulationApoptosis PharmacologyApoptosis RegulationBcl-2 Family ProteinsCell DeathBcl-2 Protein ExpressionBcl-2 Protein RegulationBcl-xl FunctionGlucocorticoid SignalingMelatonin ImmunomodulationMelatonin TreatmentMitochondrial Pathway Of ApoptosisRegulation By Bcl-2 Family Proteins
The antiapoptotic effect of melatonin has been described in several systems. In this study, the antagonistic effect of the methoxyindole on dexamethasone-induced apoptosis in mouse thymocytes was examined. Melatonin decreased both DNA fragmentation, and the number of annexin V-positive cells incubated in the presence of dexamethasone. Analysis of the expression of the members of the Bcl-2 family indicated that the synthetic glucocorticoid increased Bax protein levels without affecting the levels of Bcl-2, Bcl-XL, Bcl-XS, or Bak. This effect correlated with an increase in thymocytes bax mRNA levels. Dexamethasone also increased the release of cytochrome C from mitochondria. All of these effects were reduced in the presence of melatonin, which was ineffective per se on these parameters. In addition, the involvement of cAMP on glucocorticoid/melatonin antagonism was examined. Both melatonin and dexamethasone decreased the levels of this nucleotide in mouse thymocytes, indicating that the antagonistic action between both hormones involves a cAMP-independent pathway. In summary, the present results suggest that the antiapoptotic effect of melatonin on glucocorticoid-treated thymocytes would be a consequence of an inhibition of the mitochondrial pathway, presumably through the regulation of Bax protein levels.
42
Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c
Xuesong Liu, Caryn Naekyung Kim, Jie Yang et al. · Cell · 1996 · 5.2K citations · Full text